425: HSPT Corrects Proxy Details for SL Bio Merger Vote

Horizon Space Acquisition II Corp. filed an 8-K to correct trust and transfer agent contact information and redemption details in its definitive proxy statement for the upcoming SL Bio business combination vote.

Summary

• Horizon Space Acquisition II Corp. (HSPT) filed a Current Report on Form 8-K to correct specific details in its Definitive Proxy Statement, originally filed on January 13, 2026.
• The corrections pertain to the trust agent, transfer agent, and their contact information, as well as detailed redemption rights procedures for the proposed business combination with SL BIO Ltd. (SL Bio).
• The Trust Account is maintained by Wilmington Trust, National Association.
• Advantage Proxy, Inc. is identified as HSPT's proxy solicitor, with contact details provided.
• VStock Transfer, LLC is the transfer agent for share redemptions, with contact details provided.
• The deadline for shareholders to make a Redemption Election is 5:00 pm Eastern Time on January 30, 2026.
• Shareholders must deliver their shares to the transfer agent two business days prior to the Extraordinary Meeting to exercise redemption rights.
• The Extraordinary General Meeting to vote on the Business Combination is scheduled for February 3, 2026.

Sentiment

Score: 5

Explanation: The filing is a neutral, procedural correction to a previously issued proxy statement. It clarifies important details for shareholders regarding the business combination vote and redemption process, which is positive for transparency, but does not introduce new positive or negative operational or financial news.

Positives

• The company is providing updated and accurate information to shareholders, ensuring clarity for the upcoming vote and redemption process.

Risks

• The Business Combination may be consummated even if a substantial number of shareholders redeem their shares, potentially reducing the funds available from the Trust Account and the number of HSPT shareholders.
• Significant redemptions could lead to a less liquid trading market for PubCo Ordinary Shares post-Business Combination.
• There is a risk that PubCo may not be able to meet Nasdaq listing standards if redemptions are significant.
• The combined company (SL Bio or PubCo) has a limited operating history.
• Risks include the ability of SL Bio or the combined company to identify and integrate acquisitions.
• General economic and market conditions could impact demand for the products of SL Bio or the combined company.
• There is a risk of inability to complete the proposed Business Combination.
• The anticipated benefits of the proposed Business Combination may not be recognized, potentially affected by the amount of cash available after redemptions.
• Costs related to the proposed Business Combination could be higher than expected.
• The proposed Business Combination might not close due to failure to receive required security holder approvals or other closing conditions.

Future Outlook

The combined company anticipates potential growth, but its cash position post-closing is subject to shareholder redemptions. The ability to meet Nasdaq listing standards after the business combination is a key condition. The company disclaims any obligation to update forward-looking statements unless required by law.

Management Comments

• HSPT anticipates that a public shareholder that tenders shares for redemption in connection with the vote to approve the Business Combination Proposals would receive payment of the redemption price for such shares as soon as practical after the completion of the Second Merger.
• It is HSPT’s understanding that shareholders should generally allot at least two weeks to obtain physical certificates from the transfer agent.
• HSPT does not have any control over this process or over the brokers or DTC, and it may take longer than two weeks to obtain a physical share certificate.

Industry Context

This filing is typical for a Special Purpose Acquisition Company (SPAC) nearing the completion of its de-SPAC transaction. SPACs like Horizon Space Acquisition II Corp. (HSPT) merge with private companies (SL Bio) to take them public. The detailed proxy statement and redemption process are standard elements of such transactions, reflecting regulatory requirements and shareholder rights in SPAC mergers. The emphasis on potential redemptions and their impact on liquidity and listing standards is a common concern in the current SPAC market environment.

Stakeholder Impact

• Shareholders: Provided with corrected and clarified information regarding the business combination vote and redemption rights, enabling more informed decisions. Those seeking redemption have clear instructions and deadlines. Potential impact on share liquidity and Nasdaq listing standards due to redemptions.
• Management: Ensures compliance with SEC regulations by correcting previously filed information, facilitating a smoother business combination process.
• Regulators: The filing demonstrates adherence to SEC disclosure requirements.

Next Steps

• Shareholders to review the corrected Definitive Proxy Statement.
• Shareholders to contact Advantage Proxy, Inc. for questions about proposals or additional materials by January 27, 2026.
• Shareholders intending to redeem shares must deliver them to VStock Transfer, LLC by January 30, 2026.
• Extraordinary General Meeting to be held on February 3, 2026, to vote on the Business Combination.
• Completion of the Business Combination, subject to shareholder approval and Nasdaq listing conditions.

Key Dates

Keywords

SPAC, Business Combination, Proxy Statement, Redemption Rights, SEC Filing, HSPT, SL Bio, Nasdaq Listing, Corporate Governance, Merger